Right Heart Catheterization Procedure and Indications

Right heart catheterization is a diagnostic procedure in which a thin, flexible tube is threaded through a vein and guided into the right side of the heart and the pulmonary artery to directly measure pressures and blood flow. It remains the gold standard for diagnosing pulmonary hypertension, evaluating heart failure severity, and guiding treatment in cardiogenic shock. Despite being a bedside staple in intensive care units for decades, the procedure’s role has evolved considerably, with newer evidence reshaping when, why, and how clinicians use it.

What the Catheter Actually Measures

The catheter travels from a vein through the right atrium, into the right ventricle, and out into the pulmonary artery. Along the way, it records pressures at each stop. A balloon at the catheter tip can be inflated briefly to “wedge” in a small pulmonary artery branch, giving an indirect estimate of pressure on the left side of the heart without needing to cross the aortic valve. These measurements paint a detailed picture of how well the heart is pumping, how much resistance the lungs are putting up against blood flow, and whether fluid is backing up on one or both sides of the circulation.¹

The key numbers that come out of the procedure include right atrial pressure, right ventricular pressure, pulmonary artery pressure, pulmonary capillary wedge pressure (the surrogate for left-sided filling pressure), and cardiac output. From these, clinicians can calculate pulmonary vascular resistance, which is critical for distinguishing different types of pulmonary hypertension and for deciding whether a patient can safely receive a heart transplant.

How Cardiac Output Is Measured, and Why It Gets Complicated

Cardiac output, the volume of blood the heart pumps each minute, is one of the most important numbers derived from right heart catheterization. Two main methods are used to estimate it: thermodilution and the Fick method. Thermodilution involves injecting a small bolus of cold saline through the catheter and measuring how quickly the temperature change dissipates downstream. The Fick method calculates output from oxygen consumption and the difference in oxygen content between arterial and venous blood. In theory, either approach should give you the same answer. In practice, they often do not.

A large study of over 12,000 patients found that the two methods correlated only modestly, and their estimates differed by more than 20% in roughly 38% of patients. The average difference between them was tiny, but the spread around that average was enormous, meaning that for any individual patient, one method could give a substantially different reading than the other. When the researchers checked which method better predicted death within 90 days and one year, thermodilution came out ahead.²

A separate comparison against the “true” Fick method using directly measured oxygen consumption found a similar picture. The median error between Fick and thermodilution was about 17.5%, and more than 30% of patients had errors exceeding 25%. The overall correlation was again modest, and the authors concluded that thermodilution introduces a non-directional error that limits the confidence clinicians should place in any single reading.³ During exercise testing, the discrepancy worsens: thermodilution tends to underestimate output at rest and overestimate it at peak exercise, with the limits of agreement widening considerably under exertion.⁴

What this means for patients is that cardiac output is less precise than it looks on paper. Experienced clinicians treat the number as one piece of a puzzle, interpreting it alongside pressure tracings, physical exam findings, and imaging. A single cardiac output reading that does not match the clinical picture may prompt repeat measurements or a switch to the other technique.

Where the Catheter Goes In

Traditionally, the catheter is inserted through a large central vein in the neck (internal jugular) or the groin (femoral). Both work well, but each has drawbacks: neck access carries a small risk of puncturing the lung or hitting the carotid artery, while groin access requires the patient to lie flat afterward and is associated with more hematomas. Over the past decade, there has been growing interest in using arm veins instead, with studies comparing peripheral approaches to the traditional central routes.

A meta-analysis pooling over 6,500 procedures found that the overall complication rate for right heart catheterization was low at about 1%. Peripheral venous access through the arm had a significantly lower complication rate than central venous access, roughly 0.1% versus 1.2%. Jugular access had the numerically highest complication rate at 2%, though the difference from peripheral access did not reach statistical significance in that analysis, likely due to limited sample sizes in some comparisons.⁵

A study of over 1,000 procedures found that the antecubital (inner elbow) approach was successful in about 93% of eligible patients and was associated with shorter procedure times, less fluoroscopy, and lower radiation exposure compared with femoral access. Hematomas at the puncture site were significantly more common with the femoral approach.⁶ Another group compared brachial vein access to internal jugular access and found equivalent procedural times, very low complications overall (0.6%, all in the neck group), and a clear patient preference for the arm.⁷ The practical upshot is that arm access is gaining ground as a default for outpatient diagnostic catheterizations, especially when a tissue biopsy is not needed.

Safety Profile

A large prospective study across experienced pulmonary hypertension centers found a serious adverse event rate of about 1.1% across nearly 7,000 procedures. The most frequent complications were access-site problems like hematomas and, rarely, pneumothorax, followed by abnormal heart rhythms and low blood pressure during vasoreactivity testing. The vast majority of these complications were mild to moderate and resolved on their own or with straightforward treatment. Procedure-related death was extremely rare, occurring in 4 out of roughly 7,000 procedures, or about 0.055%.⁸

Catheter-related complications that have been reported in the literature include injury to the tricuspid valve (the valve between the right atrium and right ventricle that the catheter crosses), knotting of the catheter, and, rarely, pulmonary artery rupture. A review of published case reports found that tricuspid valve injury was the most commonly described catheter-related complication, while carotid artery puncture and arteriovenous fistula formation were the most commonly reported access-site issues.⁹ These serious complications are genuinely rare, but they underscore why the procedure should be done in experienced hands for clear clinical indications.

Pulmonary Hypertension Diagnosis and Vasoreactivity Testing

Right heart catheterization is required for the definitive diagnosis of pulmonary hypertension. Echocardiography can suggest elevated pulmonary pressures, but it cannot confirm the diagnosis or tell you what is causing it. The catheter allows clinicians to measure mean pulmonary artery pressure directly and, combined with the wedge pressure, to classify the hypertension as precapillary (a problem in the lung blood vessels themselves), postcapillary (caused by left heart disease), or a combination of both. That distinction fundamentally changes treatment.

During catheterization for pulmonary arterial hypertension, clinicians often perform vasoreactivity testing: administering a short-acting vasodilator like inhaled nitric oxide to see whether the pulmonary arteries relax. A positive response identifies a subset of patients who may benefit from calcium channel blocker therapy, a relatively inexpensive oral treatment. Provocation techniques during catheterization can also help sub-characterize the type of pulmonary hypertension and guide treatment decisions.¹⁰

Even in forms of pulmonary hypertension traditionally considered “fixed,” vasoreactivity can be surprisingly variable. A study of 49 patients with chronic thromboembolic pulmonary hypertension, a condition caused by old blood clots in the lungs, found that about 29% had a meaningful drop in pulmonary vascular resistance with supplemental oxygen alone, and 61% responded when oxygen was combined with inhaled nitric oxide. This confirmed that the disease involves a significant component of active blood vessel constriction on top of the mechanical obstruction from clots.¹¹

Why Echocardiography Cannot Replace It

Echocardiography is noninvasive, widely available, and quick. It estimates pulmonary artery pressure by measuring the speed of a tiny jet of blood leaking backward through the tricuspid valve. For screening purposes, it works reasonably well. A large analysis found good sensitivity (87%) and specificity (79%) for detecting pulmonary hypertension, with an overall diagnostic accuracy of 85%.¹²

The problem is precision for individual patients. While average echocardiographic estimates of mean pulmonary artery pressure match catheter readings closely at the population level, the scatter around any individual estimate is wide. One study found limits of agreement spanning roughly 37 mmHg for mean pulmonary artery pressure, meaning echo could overestimate or underestimate the true value by nearly 20 mmHg in either direction for a given patient.¹³ Another study found that while echocardiography showed good agreement with catheterization for detecting high pressures, its accuracy for individual diagnostic decisions was only about 43%, and suggested that a higher echo cutoff would be needed to achieve acceptable specificity for confirming the diagnosis.¹⁴

In practice, this means echocardiography is a solid first step. If it suggests normal pressures and the clinical suspicion for pulmonary hypertension is low, catheterization can often be avoided. But if treatment decisions hinge on the exact pressure or on classifying the type of hypertension, the catheter is still necessary.

Exercise Right Heart Catheterization

Some patients have normal pressures at rest but develop abnormal hemodynamics when they exert themselves. This is particularly relevant in heart failure with preserved ejection fraction, a condition where the heart’s pumping strength looks normal on imaging but the heart is stiff and cannot fill properly during exercise. Exercise right heart catheterization, in which the patient pedals a supine bicycle while pressure measurements are taken, is considered the gold standard for diagnosing this condition.¹⁵ During exercise, the wedge pressure rises disproportionately in these patients, unmasking the filling abnormality that resting measurements miss. This technique has increasingly shifted clinical practice, because a normal resting catheterization no longer rules out significant heart failure in a patient with unexplained exercise intolerance.

The Catheter in Cardiogenic Shock

Cardiogenic shock, where the heart suddenly fails to pump enough blood to sustain organ function, is one of the most lethal emergencies in medicine. Whether pulmonary artery catheters improve outcomes in the intensive care unit has been debated for decades. Early randomized trials found no clear benefit, and some clinicians moved away from routine catheter use in critical care. But the picture has shifted for one specific scenario: heart failure-related cardiogenic shock.

A study of over 1,000 patients with heart failure cardiogenic shock found that those who received a pulmonary artery catheter during hospitalization had lower adjusted in-hospital mortality, about 22% compared with 30% in those who did not receive one. Early catheter placement, within six hours of admission, was associated with even better outcomes, with adjusted mortality of about 17% versus 28% for delayed or no catheter use.¹⁶ A systematic review and meta-analysis echoed these findings, reporting that patients who received a pulmonary artery catheter had better in-hospital survival.¹⁷

These are observational findings, and sicker patients who die very quickly may never make it to catheterization, biasing the results. Still, the signal is consistent enough that many heart failure specialists now advocate for early catheter placement in cardiogenic shock, viewing the pressure data as essential for titrating intravenous medications, deciding when to escalate to mechanical circulatory support, and identifying right ventricular failure that might otherwise go unrecognized.

Heart Transplant Evaluation

Right heart catheterization plays a gatekeeping role in the heart transplant process. A donor heart, which has been functioning in a body with normal lung pressures, can fail catastrophically if implanted into a recipient whose pulmonary vascular resistance is too high. The right ventricle of the new heart simply cannot overcome the resistance. For this reason, transplant programs require catheterization to measure pulmonary vascular resistance before listing a patient for transplant.

Patients with a pulmonary vascular resistance above roughly 5 to 6 Wood units that does not respond to vasodilator testing are generally considered too high-risk for transplant.¹⁸ But this is not always a permanent disqualification. In one case report, a patient with extraordinarily elevated resistance (nearly 16 Wood units) was treated with aggressive medical therapy and then a left ventricular assist device. Serial catheterizations showed the resistance falling from 16 to about 3.4 Wood units within two months, and to 2.2 Wood units at one year, eventually making transplantation feasible.¹⁹ The catheter, in this context, is not just a diagnostic tool but a serial monitor that tracks whether the lung vasculature is remodeling favorably over time.

Distinguishing Constrictive Pericarditis From Restrictive Cardiomyopathy

One of the more challenging diagnostic puzzles in cardiology is telling constrictive pericarditis (a thickened, stiffened sac around the heart) apart from restrictive cardiomyopathy (a stiff heart muscle). Both produce similar symptoms and similar-looking echocardiograms. The distinction matters enormously because constrictive pericarditis is surgically curable by stripping away the pericardium, while restrictive cardiomyopathy generally is not.

Right heart catheterization with simultaneous left heart pressure measurement can differentiate the two by examining how the ventricles interact during breathing. In constrictive pericarditis, the rigid shell around the heart causes the right and left ventricles to compete for space with each breath, producing a characteristic pattern in the pressure tracings. One study found that a specific measure of this ventricular interdependence, the systolic area index, had a sensitivity of 97% and a predictive accuracy of 100% for identifying surgically confirmed constrictive pericarditis.²⁰ This is one of the clearest examples of catheterization answering a question that no other test can answer reliably.

Implantable Pressure Sensors and Remote Monitoring

A natural extension of right heart catheterization is the idea of leaving a small pressure sensor permanently inside the pulmonary artery so that pressures can be tracked continuously at home. The CardioMEMS device does exactly this. Once implanted during a brief catheterization-like procedure, the sensor transmits daily pressure readings to the patient’s care team, who can adjust diuretics and other medications proactively before fluid overload leads to a hospital admission.

A meta-analysis of three randomized trials found that patients managed with pulmonary artery pressure monitoring had about 30% fewer heart failure hospitalizations compared with control patients receiving standard care.²¹ Real-world data from a post-approval registry of over 1,200 patients showed an even larger effect: heart failure hospitalizations dropped by more than half in the year after implantation compared with the year before, and all-cause hospitalizations fell by about 27%.²²

The technology represents a shift in how catheterization-derived data is used. Instead of a single snapshot during a hospital visit, clinicians get a continuous movie of a patient’s hemodynamics, catching rising pressures days or weeks before the patient feels sick enough to come to the emergency department.

MRI-Guided Catheterization

Conventional right heart catheterization relies on X-ray fluoroscopy to see where the catheter is going, which exposes patients and staff to ionizing radiation. For most adults undergoing a single procedure, the radiation dose is low and clinically inconsequential. But for children with congenital heart disease who may need dozens of catheterizations over a lifetime, cumulative exposure is a genuine concern.

Researchers have been developing MRI-guided catheterization as a radiation-free alternative. Early work demonstrated that comprehensive right heart catheterization could be performed entirely under MRI guidance in adults, with catheter visibility achieved using gadolinium-filled balloon tips. Procedure times were comparable to conventional fluoroscopy.²³ Pediatric studies have confirmed feasibility and safety in children, including those with metallic implants and those requiring continuous medication infusions, populations that might have been assumed to be poor MRI candidates.²⁴

More recently, investigators have demonstrated that both right and left heart catheterization, along with angioplasty and stenting, are technically feasible under real-time MRI on a commercially available low-field scanner, a step that brings the technique closer to routine clinical use.²⁵ MRI guidance also offers the bonus of simultaneously acquiring flow and tissue data that fluoroscopy simply cannot provide, potentially turning a diagnostic catheterization into a combined imaging and hemodynamic assessment in one session. For congenital heart disease patients who already need both MRI and catheterization at regular intervals, collapsing the two into a single procedure is an appealing proposition.²⁶